Data / Form D filings / Passage BIO, Inc.
Passage BIO, Inc.: Form D filing
Passage BIO, Inc., a health care company in Philadelphia, PA, filed a Form D with the SEC in 2019. The latest, on September 6, 2019, reports $110 million sold of a $110 million offering to 15 investors.
Find out what Passage BIO, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- TWO COMMERCE SQUARE, 2001 MARKET STREET, 28TH FLOOR, Philadelphia, PA, 19103
- Phone
- (267) 866-0312
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Investment Company Act section 3(c), section 3(c)(1)
- SEC identifier (CIK)
- 1787297
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 6, 2019 | New notice | $110,000,000 | $109,999,974 | $26 | 15 | Aug 21, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Heron | Director | |
| Carl Gordon | Director | |
| Tadataka Yamada | Executive Officer, Director, Promoter | |
| Saqib Islam | Director | |
| Thomas Street Address 1 Woiwode | Director | |
| Stephen Squinto | Executive Officer, Director |
Other health care companies in Pennsylvania that filed recently
- Septal Solutions, Inc. $7.3 million · Oct 27, 2026
- Lungpacer Medical, Inc. $7.8 million · Oct 14, 2026
- Plowshare Holdings LLC $7.8 million · Oct 14, 2026
- Peca Labs, Inc. $12.8 million · Oct 9, 2026
- McAllen Digestive Surgery Center, LLC offering · Sep 30, 2026
- Toetal Solutions, Inc. $50,000 · Sep 24, 2026
- Opyn Health, Inc. offering · Sep 4, 2026
- Lumis Corp. $100,000 · Aug 21, 2026
Every Form D from the week of Sep 2, 2019 · All recent filings in Pennsylvania · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Passage BIO, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.